Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

Company Data

Name Aspire Biopharma Holdings, Inc. - Warrant

Company Aspire Biopharma Holdings, Inc.

Symbol ASBPW

Website https://aspirebiolabs.com

Primary Exchange

NASDAQ

ISIN US7389201150

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Kraig T. Higginson

Country United States of America

Currency USD

Employees 0,0 T

Address 188 Grand Street, Unit 195, 10013 Humacao

IPO Date 2022-04-11

ID Changes

Date	From	To
20.02.2025	PWUPW	ASBPW

Ticker Symbols

Name	Symbol
NASDAQ	ASBPW

More Shares

Investors who hold Aspire Biopharma Holdings, Inc. - Warrant also have the following shares in their portfolio:

DZ BANK IS.A1958 Bond

MET.LIFE F.I 22/27 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog